Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant <i>Staphylococcus aureus</i> Endocarditis

Abstract

Slow clinical response is common among patients with MRSA endocarditis who are treated with vancomycin or vancomycin plus rifampin. Nevertheless, few complications appear to be related solely to this sustained bacteremia.